
Nordson (NDSN) Stock Forecast & Price Target
Nordson (NDSN) Analyst Ratings
Bulls say
Nordson demonstrated solid performance in its fiscal reports, with overall revenue reaching approximately $2.8 billion for fiscal 2025, supported by a diverse portfolio across multiple high-demand segments. The company showcased strong organic sales growth, particularly in its Advanced Technology Solutions segment, which experienced a 21% increase, alongside steady contributions from its Medical and Fluid Solutions and Industrial Precision Solutions segments. Furthermore, Nordson's upward revision of FY26 sales expectations to a range of $2.86 billion to $2.98 billion indicates sustained momentum and confidence in its operational strength and market demand.
Bears say
Nordson reported an adjusted operating profit of $166 million, which was $5 million below estimates, reflecting a decline in EBITDA margins within its Industrial Precision Solutions segment due to an unfavorable product mix and reduced leverage from foreign exchange benefits. In the Medical and Fluid Solutions segment, revenue declined by 0.2%, primarily impacted by divestitures and foreign exchange fluctuations, indicating challenges in sustaining growth amidst shifting market dynamics. Additionally, the company's flat net leverage of 2.1x, despite healthy free cash flow conversion, raises concerns about financial flexibility and long-term growth prospects, especially in light of external currency pressures.
This aggregate rating is based on analysts' research of Nordson and is not a guaranteed prediction by Public.com or investment advice.
Nordson (NDSN) Analyst Forecast & Price Prediction
Start investing in Nordson (NDSN)
Order type
Buy in
Order amount
Est. shares
0 shares